Novo Integrated Sciences Yönetim
Yönetim kriter kontrolleri 4/4
Novo Integrated Sciences' CEO is Rob Mattacchione, appointed in Oct 2018, has a tenure of 6.08 years. total yearly compensation is $185.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 6.77% of the company’s shares, worth $228.35K. The average tenure of the management team and the board of directors is 2.6 years and 3.7 years respectively.
Anahtar bilgiler
Rob Mattacchione
İcra Kurulu Başkanı
US$185.0k
Toplam tazminat
| CEO maaş yüzdesi | 100.0% |
| CEO görev süresi | 6.1yrs |
| CEO sahipliği | 6.8% |
| Yönetim ortalama görev süresi | 2.6yrs |
| Yönetim Kurulu ortalama görev süresi | 3.7yrs |
Son yönetim güncellemeleri
Recent updates
Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch
Jul 11
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump
Apr 18Novo Integrated Sciences prices 4M unit public offering at $.50/unit
Oct 14Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue
Jul 11Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?
Nov 23Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Aug 07Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Mar 02CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| May 31 2024 | n/a | n/a | -US$24m |
| Feb 29 2024 | n/a | n/a | -US$12m |
| Nov 30 2023 | n/a | n/a | -US$14m |
| Aug 31 2023 | US$185k | US$185k | -US$13m |
| May 31 2023 | n/a | n/a | -US$32m |
| Feb 28 2023 | n/a | n/a | -US$35m |
| Nov 30 2022 | n/a | n/a | -US$35m |
| Aug 31 2022 | US$185k | US$185k | -US$33m |
| May 31 2022 | n/a | n/a | -US$12m |
| Feb 28 2022 | n/a | n/a | -US$9m |
| Nov 30 2021 | n/a | n/a | -US$5m |
| Aug 31 2021 | US$47k | US$47k | -US$4m |
Tazminat ve Piyasa: Rob's total compensation ($USD185.00K) is below average for companies of similar size in the US market ($USD655.65K).
Tazminat ve Kazançlar: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Mattacchione (56 yo)
6.1yrs
Görev süresi
US$185,000
Tazminat
Mr. Robert Mattacchione, also known as Rob, is Chairman of the Board and Chief Executive Officer at Novo Integrated Sciences, Inc. since October 2018. He is the Co-Owner at Mattacchione Family Trust. He is...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.1yrs | US$185.00k | 6.77% $ 228.4k | |
| COO & Director | 3.4yrs | US$434.56k | 0.043% $ 1.4k | |
| President | less than a year | US$81.03k | Veri yok | |
| Principal Financial Officer & Principal Accounting Officer | 1.3yrs | Veri yok | Veri yok | |
| Chief Medical Officer & Chairman of Medical Advisory Board | 2.6yrs | Veri yok | Veri yok |
2.6yrs
Ortalama Görev Süresi
58yo
Ortalama Yaş
Deneyimli Yönetim: NVOS's management team is considered experienced (2.6 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.1yrs | US$185.00k | 6.77% $ 228.4k | |
| COO & Director | 10.3yrs | US$434.56k | 0.043% $ 1.4k | |
| Chief Medical Officer & Chairman of Medical Advisory Board | 3.6yrs | Veri yok | Veri yok | |
| Member of Medical Advisory Board | 3.6yrs | Veri yok | Veri yok | |
| Independent Director | 3.8yrs | US$15.00k | 0% $ 0 | |
| Independent Director | 3.8yrs | Veri yok | 0% $ 0 | |
| Member of Medical Advisory Board | 3.6yrs | Veri yok | Veri yok | |
| Independent Director | 2.4yrs | Veri yok | 0% $ 0 |
3.7yrs
Ortalama Görev Süresi
52.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: NVOS's board of directors are considered experienced (3.7 years average tenure).